Federal Court upholds cancellation of reconsideration of Apotex’s ANDS for Apo-omeprazole

Published date09 November 2017
AuthorJonathan Chong, Sara Zborovski and Brian Daley
Subject MatterFood, Drug & Agriculture,Health Care
Law FirmPharma in Brief

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT